Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Transitional Drugs 3

Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts

This public procurement record has 2 releases in its history.

Award

14 May 2025 at 19:27

Award Notice
Tender

19 Dec 2024 at 14:50

Tender Notice
Summary of the contracting process

The public procurement process titled "Transitional Drugs 3" was handled by Velindre NHS Trust, acting on behalf of NHS Wales Shared Services Partnership, covering all Wales UHBs & Trusts. This procurement falls under the pharmaceutical products industry category and aims to acquire drugs that have recently lost their patent exclusivity. Buyers and suppliers are operating within the UK, and the main location of delivery is in the UKL region. The procurement was conducted through an open procedure, reflecting its commitment to transparency and competition. The tender process began with an announcement on 19th December 2024 and submissions closed on 23rd January 2025. The award phase commenced immediately after, with contracts being signed by 15th April 2025. This tender was successfully awarded to multiple suppliers, with the process currently in the award stage and all contracts deemed active.

This procurement process offers valuable opportunities for businesses in the pharmaceutical industry, particularly those capable of supplying high-quality goods at competitive prices. With a focus on quality, cost, and social value, the tender was an ideal fit for established pharmaceutical companies. The awarded contracts, each carrying significant financial value, are likely to provide robust growth avenues for suppliers like Celltrion Healthcare UK Ltd and Amgen Ltd, among others, potentially expanding their footprint within the UK healthcare market. Businesses with capabilities in drug manufacturing and distribution, particularly those with expertise in pharmaceuticals losing patent exclusivity, would find this tender suitable for scaling operations and increasing market share within the healthcare procurement sector. The framework also offers an extension option, further enhancing long-term business prospects.

How relevant is this notice?

Notice Information

Notice Title

Transitional Drugs 3

Notice Description

Drugs which have recently lost their patent exclusivity

Lot Information

Lot 1

Transitional Drugs 3

Renewal: This framework includes the option to extend for up to a further 24 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04c9a9
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/021504-2025
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£15,169,777 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£29,045,630 £10M-£100M

Notice Dates

Publication Date
14 May 20251 years ago
Submission Deadline
23 Jan 2025Expired
Future Notice Date
Not specified
Award Date
15 Apr 20251 years ago
Contract Period
1 Apr 2025 - 30 Jun 2026 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts
Additional Buyers

Velindre NHS Trust

Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
NEWPORT
Postcode
NP10 8BE
Postcode Area
Newport
Country
Wales
Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL54 Monmouthshire and Newport
Delivery Location
TLL Wales
Local Authority
Newport
Electoral Ward
Tredegar Park and Marshfield
Westminster Constituency
Newport West and Islwyn

Supplier Information

Number of Suppliers
11
Supplier Names

Amgen Ltd

Biogen Idec Ltd

Celix Pharma

Celltrion Healthcare Uk Ltd

Fresenius Kabi Ltd

Roche Products Ltd

Sandoz Ltd

Sun Pharma Ltd

Thornton & Ross Ltd

Tillomed Laboratories Ltd

Zentiva Ltd

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...